Androgen, estrogen and progestin binding in cytosols of benign gynecologic tumors and tumor-like lesions.
Specific androgen (Kd 0.27 +/- 0.06 nM), estrogen (Kd 0.19 +/- 0.04 nM) and progestin (Kd 0.22 +/- 0.07 nM) binding were investigated in benign gynecologic tumors and tumor-like lesions. The simultaneous presence of androgen and progestin receptors was a common finding. In one endometrioma, specific androgen, estrogen and progestin binding was observed simultaneously.
D000328:Adult; D000368:Aged; D003537:Cystadenoma / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004407:Dysgerminoma / Q000378:metabolism; D004715:Endometriosis / Q000378:metabolism; D005260:Female; D006801:Humans; D008875:Middle Aged; D010048:Ovarian Cysts / Q000378:metabolism; D010051:Ovarian Neoplasms / Q000378:metabolism*; D011944:Receptors, Androgen / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*
D011944:Receptors, Androgen; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone